Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia.
Cell Metab. 2022 Jun 7;34(6):919-936.e8. doi: 10.1016/j.cmet.2022.05.004.
Cell Metab. 2022.
PMID: 35675800